Hong Kong PR

中國香港 - 由香港特區政府、香港貿易發展局主辦的第十屆“一帶一路”峰會，於2025年9月10日至11日在香港會展中心舉辦。與會中亞領先的穩定幣發行機構AnchorX，作為首家獲得哈薩克斯坦AFSA（阿斯塔納金融服務管理局）牌照的穩定幣發行商，正式發佈掛鉤離岸人民幣的穩定幣AxCNH。AnchorX與聯想、中聯重科、朗華國際、ATAIX及Conflux樹圖達成重要合作備忘錄，共同探索AxCNH在跨境支付、貿易結算、數字資產交易及實物資產代幣化（RWA）等領域的應用。AxCNH致力為離岸中資企業及“一帶一路”沿線國家合作夥伴提供高效便捷的跨境支付與貿易結算解決方案。 2024年中國與“一帶一路”沿線國家貿易總額達22.1萬億元，占中國外貿總額的50.3%。AnchorX與全球工程機械龍頭中聯重科在本次“一帶一路”峰會上達成的重要合作就是一個典型案例。目前，中聯重科業務覆蓋超100個國家，並在“一帶一路”沿線地區有強大的業務網路；2024年中聯重科的海外營收達234億元，占總營收比重超50%。此前，雙方已在Conflux樹圖區塊鏈上成功完成了AxCNH交易測試。未來，雙方將進一步合作優化跨境支付與貿易結算流程，助力中聯重科及其“一帶一路”合作夥伴簡化跨境結算流程，實現降本增效。 與會AnchorX還與哈薩克斯坦領先的持牌加密貨幣交易所ATAIX簽訂了上線AxCNH穩定幣的協議，並已在Conflux樹圖區塊鏈完成AxCNH的智能合約部署和測試。AxCNH將在ATAIX交易平臺上線兩個交易對——AxCNH/KZT（哈薩克斯坦堅戈）與AxCNH/USDT（現階段僅對專業投資者開放）。作為首個持牌的離岸人民幣穩定幣，AxCNH的推出具有里程碑意義。隨著中國與“一帶一路”沿線國家貿易規模持續擴大，AnchorX希望AxCNH成為提升“一帶一路”企業的貿易效率、降低匯率波動風險的關鍵基礎設施，減少跨境交易的時間和費用成本，助推人民幣國際化。

Hongkong, China - At the 10th Belt and Road Summit in Hong Kong, jointly organized by the Government of the Hong Kong SAR and the Hong Kong Trade Development Council, AnchorX, a leading stablecoin issuer from Central Asia and the first recipient of a stablecoin license from the Astana Financial Services Authority (AFSA) in Kazakhstan, officially announced the launch of AxCNH, a stablecoin pegged to the offshore Chinese Yuan (CNH). The company signed key Memorandums of Understanding (MoUs) with Zoomlion, Lenovo, China Brilliant Global, ATAIX, and Conflux to explore AxCNH’s applications in cross-border payments, trade settlements, digital asset trading, and Real-World Asset (RWA) tokenization. AxCNH is designed to facilitate seamless cross-border payments and settlements for offshore Chinese enterprises and Belt and Road Initiative (BRI) countries. In 2024, China’s total trade volume with BRI nations reached RMB 22.1 trillion, accounting for 50.3% of the country’s total trade volume. Among its strategic collaborations, AnchorX has partnered with Zoomlion, a global leader in mechanical equipment manufacturing with operations in over 100 countries and a significant presence across BRI regions. In 2024, Zoomlion reported overseas revenue of RMB 23.4 billion, accounting for more than 50% of its total revenue. AnchorX and Zoomlion have successfully tested AxCNH transactions on the Conflux blockchain network. Looking ahead, the two companies will collaborate to enhance cross-border payments using AxCNH, enabling Zoomlion and its BRI partners to streamline settlements with greater efficiency and reduced costs. AnchorX has also secured a listing agreement with ATAIX Eurasia, a leading licensed cryptocurrency exchange in Kazakhstan, and deployed AxCNH on the Conflux blockchain, where initial testing took place. AxCNH will be available for trading on the ATAIX platform in two pairs: AxCNH:KZT and AxCNH:USDT, with access currently limited to Professional Clients. The launch of AxCNH marks a significant milestone as the first licensed offshore Yuan-pegged stablecoin. As trade between China and BRI countries continues to expand, AnchorX positions AxCNH as an important infrastructure tool to enhance trade efficiency, reduce exchange rate volatility, and lower transaction costs for enterprises operating across BRI economies, thereby supporting the internationalization of CNH.

A groundbreaking month of music and culture sees sureWin partner with global icons, offering fans exclusive experiences and shaping the future of live entertainment in Asia Kuala Lumpur, Malaysia – 2025 – In a rare feat for Asia’s live entertainment industry, sureWin has become the only regional brand this year to partner with both a top K-pop idol and a global pop group within the same month. The company first joined forces with Daesung, one of K-pop’s most celebrated vocalists, before extending its reach to collaborate with the Black Eyed Peas, the iconic American group known for their global chart-topping hits. These back-to-back partnerships highlight sureWin’s growing influence in shaping Asia’s entertainment landscape through high-profile international collaborations. The back-to-back announcements attracted attention from industry observers who noted the rarity of aligning with two international headliners in such close succession. In an entertainment market where securing one major star often takes months of negotiation, sureWin demonstrated its capability to move decisively, bringing world-class music experiences to audiences while reinforcing its credibility as a trusted brand partner in live events. Daesung: A Milestone for K-pop Engagement Daesung, known internationally as a powerful vocalist and charismatic performer, brought a distinctive K-pop presence to the stage. The concert highlighted both his artistry and his ability to connect with fans across cultures. For sureWin, partnering with Daesung meant delivering more than a performance; it was about creating a milestone moment in Asian pop culture. The collaboration included exclusive elements that allowed fans closer access to the artist, such as carefully structured VIP packages. These experiences were designed to reflect Daesung’s status in the industry while also showcasing sureWin’s ability to support events that balance large-scale appeal with personal impact. By aligning with Daesung, sureWin positioned itself at the heart of the K-pop wave that continues to dominate music markets in Asia and beyond. The event also reinforced the platform’s focus on inclusivity, attracting diverse audiences from across the region. In a market where K-pop continues to be one of the fastest-growing cultural exports, the partnership with Daesung strengthened sureWin’s reputation as a company that understands both global trends and regional fan expectations. The Black Eyed Peas: Innovation Meets Global Pop Shortly after Daesung’s concert, the spotlight shifted to the Black Eyed Peas, a group that has defined mainstream pop and hip-hop fusion for decades. Under the sureWin banner, the Black Eyed Peas delivered an energetic performance that blended their classic anthems with cutting-edge production design. The collaboration introduced a Futuristic Dress Code theme, encouraging fans to participate in a visual spectacle that extended beyond the stage. The choice of a futuristic concept reflected both the group’s history of innovation and sureWin’s commitment to modern, immersive entertainment. With state-of-the-art lighting, choreography, and sound design, the event highlighted how international acts can integrate seamlessly with local audiences when supported by the right partners. For sureWin, the collaboration proved its ability to handle productions of international scale while maintaining a consistent focus on quality and fan engagement. Ticketing benefits and exclusive access opportunities further elevated the event, demonstrating that sureWin’s approach extends beyond simple sponsorship. By providing fans with tangible advantages, the brand distinguished itself as an active contributor to the success of the performance. The result was a concert that not only entertained but also set a benchmark for how global acts can be presented in Asia through thoughtful partnership models. Dual Success in a Competitive Market In Asia’s entertainment industry, the ability to secure one high-profile partnership often defines a brand’s standing. By delivering both Daesung and the Black Eyed Peas within weeks of each other, sureWin achieved a dual success that few competitors could match. The collaborations served as proof points for the company’s resources, network, and strategic vision. This accomplishment is particularly notable given the diversity of the artists involved. Daesung represents the pinnacle of K-pop, appealing to a highly engaged regional audience, while the Black Eyed Peas embody international pop culture with a global fan base. Bringing these two distinct acts under the same sponsorship umbrella highlighted sureWin’s versatility and ability to operate across cultural and musical boundaries. Industry analysis pointed out that such partnerships require both financial commitment and operational expertise. By executing two major events seamlessly, sureWin showed it can deliver at the highest level of professional entertainment management, reinforcing its position as a leading partner for global talent entering the Asian market. Looking Forward: It’s The Ship 2025 While the Daesung and Black Eyed Peas collaborations marked a defining moment, sureWin has already signaled that this is only the beginning. The company has confirmed its involvement in It’s The Ship 2025, one of the region’s most innovative music festivals staged aboard a luxury cruise. This upcoming project will allow sureWin to extend its entertainment presence into new formats that combine travel, community, and live performance. Unlike traditional concerts, It’s The Ship represents a multi-day cultural experience where fans live alongside artists in a shared environment. sureWin’s participation demonstrates its intention to be at the forefront of experiential entertainment, ensuring audiences encounter memorable events that blend lifestyle and music in unprecedented ways. Redefining Entertainment Standards The combination of Daesung and the Black Eyed Peas in a single month illustrates sureWin’s long-term vision. By simultaneously embracing the intimacy of a K-pop connection and the innovation of a global pop production, the company redefined what entertainment sponsorship can mean in Asia. Rather than approaching partnerships as transactional, sureWin invests in experiences that reflect the spirit of each artist while also addressing the expectations of their audiences. This strategy creates a framework where every collaboration enhances the brand’s credibility and adds measurable value to the live entertainment industry. As the region continues to attract world-class performers, sureWin has established itself as a consistent and reliable partner, capable of delivering the scale, creativity, and professionalism that international artists require. The results of this integrated approach are evident in the success of the Daesung and Black Eyed Peas events, both of which left an enduring mark on the entertainment calendar of 2025. With more projects on the horizon, sureWin is poised to continue shaping the cultural landscape. The brand’s trajectory suggests that audiences across Asia can expect even more world-class collaborations in the years ahead, ensuring that live entertainment continues to thrive with innovation and excellence at its core.

Beijing, China - September 16, 2025 - (SeaPRwire) - Southeast Asia Headlines (东南亚大事件), one of the largest independent Chinese-language news platforms in Southeast Asia, has officially surpassed 300,000 active followers on Telegram, marking a significant milestone in the rise of independent Chinese media serving overseas communities. A Trusted Platform for Southeast Asia News Since its inception, Southeast Asia Headlines has focused on delivering accurate and reliable coverage of current events in Cambodia, the Philippines, Myanmar, Thailand, and beyond. With original reporting, in-depth analysis, and verified accounts on Twitter and YouTube, the channel has become a key information hub for Chinese residents in the region. Coverage and Content The channel covers a wide range of topics, including: Political and economic newsshaping expatriates’ daily lives. Human interest storiesreflecting Chinese community experiences abroad. In-depth analysisto help followers understand complex developments. Community initiativesthat strengthen bonds between expatriates and local societies. Rapid Growth and Widespread Reach In a short time, the channel has become a preferred news source for Chinese expatriates in Southeast Asia. Its rapid growth is attributed to: Reliable, fact-checked news coverage. Direct engagement with audiences through daily interactions. Expansion across multiple trusted platforms. Related Platforms Southeast Asia Headlines also maintains official and verified accounts on: Twitter (X): https://twitter.com/okdbbot YouTube: https://youtube.com/@okdbbot This multi-platform presence further strengthens its credibility and accessibility. Official Statements “Our channel was created to be a bridge connecting Chinese expatriates with their communities in Southeast Asia. We don’t just report the news—we share people’s stories and experiences, so that every follower feels part of a cohesive community.” — Spokesperson for Southeast Asia Headlines Media Recognition The platform has gained recognition through: Coverage by Asia Presswire as part of international media reports. A dedicated Wikipedia page documenting its activities. Verified accounts on global social media platforms. Future Plans Looking ahead, Southeast Asia Headlines plans to expand its reach by: Launching weekly newsletterswith top regional news. Creating short-form video contentfor modern platforms. Partnering with local Southeast Asian media outlets. Developing in-depth research contentfor policymakers and scholars. With over 300,000 followers and growing influence, Southeast Asia Headlines has become not just a news source, but a community hub uniting Chinese expatriates across Southeast Asia. Social Links Telegram Channel: https://t.me/okdbbot Twitter: https://twitter.com/okdbbot YouTube: https://youtube.com/@okdbbot Media Contact Southeast Asia News Channel Management Email: press@okdbbot.com Telegram: https://t.me/okdbbot

Seoul Bio Hub and Celltrion Launch Strategic Gateway ‘Global Open Innovation’ to Help U.S. Bio Startups Dominate the Asian Market Two U.S.-Based Biotech and Medical Device Startups to Be Selected Based on Technology Alignment with Celltrion’s Expertise in Antibodies, Peptides, and Drug Formulation Seoul, Korea – September 16, 2025 – (SeaPRwire) – Seoul’s bio startup hub ‘Seoul Bio Hub’ and global pharmaceutical leader ‘Celltrion’ have joined forces to launch the ‘2025 Seoul Bio Hub-Celltrion Global Open Innovation (GOI)’ program. This program goes beyond a simple competition, serving as a platform designed to help U.S. startups successfully establish themselves in the Asian market. This GOI targets U.S.-based bio and medical startups, with companies established within the past 7 years eligible to apply. The recruitment areas encompass all technologies suitable for collaboration with Celltrion, including antibodies, peptides, small molecules, formulations, and cell and gene therapies. The application deadline is September 30, 2025. The selection process will proceed in the following order: Primary document evaluation Technology review Secondary presentation evaluation. The two finally selected companies will receive customized follow-up support and gain opportunities to expand into global markets through collaboration with Celltrion, leveraging South Korea’s innovative ecosystem and global capabilities. A Seoul Bio Hub representative stated, “This program will serve as a bridgehead that goes beyond simple space support, enabling U.S. startups to rapidly grow in the Asian market by leveraging Seoul’s excellent clinical infrastructure and research environment.” A Celltrion representative announced, “Based on Celltrion’s capabilities and know-how accumulated across the entire pharmaceutical industry process including R&D, production, and sales, we will support promising U.S. startups to successfully enter the Asian market and create synergy with our company.” South Korea has established itself as a bio hub leading the global market with clear numerical evidence. According to global consulting firm Intralink, South Korea’s biopharmaceutical market is valued at approximately $22 billion, ranking 13th globally. Additionally, market research firm Grand View Research forecasts that South Korea’s biotechnology market will grow to $81.6 billion (approximately 110 trillion KRW) by 2030, representing an annual average growth rate of 18.3%. Private investment is also active. From 2020 to 2022, R&D and facility investments recorded an annual average growth rate of 21.6%. This demonstrates that South Korea is not merely a potential market, but a rapidly growing innovation ecosystem. According to ClinicalTrials.gov, the global clinical trial database, Seoul has consistently maintained a top position among major global cities in the number of new clinical trials over the past decade. South Korea’s Ministry of Health and Welfare has set ‘Achieving Global 3rd Place in Clinical Trials’ as a policy objective through the ‘3rd Five-Year Plan for the Pharmaceutical and Bio Industry (2023-2027)’. Furthermore, in 2025, it raised a total of over 386.6 billion KRW through the ‘Bio Health Mega Fund’ and is actively supporting innovative companies’ clinical trials and commercialization through the national integrated bio big data construction project and AI, bio health regulatory regulatory sandboxes. Seoul Bio Hub is a bio startup support organization established by Seoul City in 2017. It provides 251 pieces of shared laboratory equipment and affordable tenant space at 10% of the cost compared to major areas in Seoul. As of May 2025, it has supported 322 startups and attracted a total of 576 billion KRW in follow-up investment, proving its potential for success. Celltrion is South Korea’s global comprehensive biotechnology company that developed the world’s first antibody biosimilar ‘Remsima’. The company performs the entire process from research and development to approval, production, and sales, supplying high-quality biopharmaceuticals to over 100 countries worldwide. Based on world-class research and production infrastructure, it contributes to expanding global access to pharmaceuticals and continues to support and collaborate with promising startups through active open innovation strategies. For detailed information regarding program applications and inquiries, please access LinkedIn, search for ‘Seoul Bio Hub’, and check the 「2025 Seoul Bio Hub-Celltrion Global Open Innovation」 recruitment announcement posted on the official company page. About Seoul Bio Hub https://www.seoulbiohub.kr/front/user/engmain.do Establishment Date: October 30, 2017 Operating Entity: Established by Seoul City / Joint operation by KIST and Korea University Location: 117-3 Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea Purpose: Growth and commercialization support for early-stage bio and healthcare startups under 10 years Tenant Companies (As of June 2025): Total 126 companies (Digital Health 42 companies (33.3%), Pharmaceuticals 61 companies (48.5%), Medical Devices 23 companies (18.2%)) Infrastructure: Laboratories, office spaces, meeting rooms, conference rooms, research equipment (249 devices, 109 types, approximately $8 million scale) Research and Human Resource Network (Regional): Approximately 7,000 PhD-level personnel, approximately 120,000 university students, $1.13 billion in research funding, connections with 12 universities and research institutions and 7 hospitals Major Support Programs: IR matching and investment linkage Expert consulting and CEO education Hospital-linked clinical and data programs Open innovation with domestic and international pharmaceutical companies About Celltrion https://www.celltrion.com/en-us Establishment Date: February 26, 2002 Location (Headquarters): 23 Academy-ro, Yeonsu-gu, Incheon Metropolitan City, Republic of Korea Business Areas and Major Products (Services) Possessing Differentiated Integrated Solutions Across the Entire Biopharmaceutical Business Process Remsima: World’s first monoclonal antibody biosimilar (TNF-α inhibitor) Herzuma: Trastuzumab biosimilar for breast and gastric cancer treatment Truxima (CT-P10): Rituximab biosimilar (lymphoma, rheumatoid arthritis, etc.) Multiple products including Zymfentra, Yuflyma, Vegzelma, Steqeyma, Avtozma are under global approval and commercialization No of Employees: Approx. 3,003 (As of June 30, 2025) Media Contact Brand: SEOUL BIO HUB Contact: Lee Yoon Jin Phone: +82 02-2200-3345 Email: lynj@kist.re.kr Website: (KOR) https://www.seoulbiohub.kr/front/user/main.do; (ENG) https://www.seoulbiohub.kr/front/user/engmain.do

Ottawa, Canada – September 16, 2025 – (SeaPRwire) – Trading Central, a pioneer in financial market research and insights, announced the launch of FIBI, AI Assistant, across its suite of research tools: Technical Insight®, TC Options Insight, TC Fundamental Insight®, and TC Market Buzz®. FIBI (‘Financial Insight Bot Interface’) leverages Trading Central’s proprietary natural language processing (NLP), language model (LM), and generative AI (GenAI) technologies—trained by the company’s award-winning data scientists and financial analysts. These models are grounded in deep expertise across technical and fundamental analysis, options trading, and market behavior. FIBI sets itself apart from generic AI and chatbots with actionable and compliance-friendly market insights powered by high-quality, real-time data. Its natural language storytelling and progressive disclosure of key insights ensure that investors of all skill-levels benefit from quality analysis without the information overload. “FIBI represents the next generation of investor enablement,” said Alain Pellier, CEO of Trading Central. “In a world flooded with generic AI content, FIBI offers a focused, trustworthy experience that’s built for action.” With FIBI, brokers can deliver a differentiated client experience — empowering investors with a tool that feels insightful, approachable and personalized, while strengthening trust in their research offering. FIBI continues Trading Central’s mission to empower investors worldwide, bridging the gap between sophisticated analysis and actionable insights. Contact Trading Central today to book your demo at sales@tradingcentral.com. About Trading Central Since 1999, Trading Central has empowered investors to make confident decisions with actionable, award-winning research. By combining expert insights with modern data visualizations, Trading Central helps investors discover trade ideas, manage risk, and identify new opportunities. Its flexible tools are designed for seamless integration across desktop and mobile platforms via iFrames, APIs, and widgets. Media Contact Brand: Trading Central Melissa Dettorre, Marketing Manager Email: marketing@tradingcentral.com  Website: https://www.tradingcentral.com

Taipei – September 15, 2025 – (SeaPRwire) – PopChill, Taiwan’s leading luxury resale platform, today announced the completion of its Series A funding round, raising US$3 million. This brings the company’s total funding to over US$9 million. The round was led by Darwin Ventures. Other participating investors include ITIC, AVA Angels, Taipei Angels (TA), and Dream coFounder. The new capital will be used to accelerate the development and application of AI technologies—including AI Agents, intelligent recommendation systems, and automated fraud prevention – aimed at upgrading the entire buyer and seller experience. Strong Growth Momentum, Cementing Market Leadership In 2024, PopChill’s transaction volume grew 120% year-over-year, reflecting robust market demand. With an average order value of US$900, the platform continues to demonstrate the deep potential of luxury resale. Cross-border transactions now account for nearly 20% of total GMV, with a solid foothold in Hong Kong and a growing global presence. The platform currently lists more than 100,000 luxury items, securing its position as Taiwan’s largest luxury resale marketplace. “Our vision is to use technology to solve inefficiencies in the luxury resale market,” said Andy Kuo, CEO of PopChill. “In the era of generative AI, PopChill is uniquely positioned to further enhance matching efficiency between buyers and sellers.” AI-Powered Innovation to Enhance User Experience At the heart of PopChill’s vision lies a belief that technology can make luxury resale seamless and trustworthy. Guided by this vision, the company is actively developing a new generation of AI tools designed to accompany both buyers and sellers throughout their journeys. The idea is to give buyers a personal shopping companion—an assistant that can one day quickly guide them to the item they have been dreaming of, shortening the path from discovery to purchase. On the seller side, PopChill is envisioning an AI partner that simplifies the listing process and ensures that details such as descriptions and categorization can be handled with ease. These initiatives are still in progress, but PopChill has already begun laying the groundwork by adopting Google Cloud Vertex AI to enhance efficiency and strengthen conversion rates. Rather than treating AI as a buzzword, the company is deliberately weaving it into its future roadmap—building toward a marketplace that is smarter, more intuitive, and more human-centered. Building a Complete Resale Ecosystem Since its early days, PopChill successfully overcame the “cold start” challenge and built a comprehensive C2C ecosystem. In addition to peer-to-peer resale, the company recently introduced a consignment model to serve sellers who prefer not to handle listings themselves. The model has already shown early success since its mid-year launch. Looking ahead, PopChill plans to establish brick-and-mortar stores to deepen online-offline integration, strengthen brand trust, and broaden consumer awareness—steps toward building a fully integrated luxury resale ecosystem. Media Contact Brand: PopChill Contact: Media team Email: support@popchill.com Website: https://www.popchill.com

2025年9月7日 - (SeaPRwire) - 9 月 5 日，開放對話專案專家會議在濱海邊疆區俄羅斯國家中心分支機構舉行。多位國際權威專家參與了此次關於貿易與互聯在新現實中的轉型討論。本次活動延續了 2025 年 4 月在莫斯科舉行的首次開放對話“世界的未來：全球增長新平臺”的主題。 印度 Jawaharlal Nehru University 國際研究學院副教授 Gulshan Sachdeva 在開放對話中表示，今天的世界多數國家（Global Majority）已不再是“第三世界”，而是新的政治、經濟與智力發展中心。 “如果我們談論世界多數國家和全球南方，如今的情況已完全不同。我們在戰略、經濟、技術乃至智力方面都實現了增長。這些國家現在主導並將繼續主導貿易、投資、技術、氣候議題等。即便僅看 BRICS，其 GDP 增長率已達 4%，到 2030 年這一份額將超過 50%。”Gulshan Sachdeva 表示。 技術創新（如數字支付、人工智慧）展示了世界多數國家的潛力。但關鍵挑戰是如何在沒有西方主導的情況下組織聯合架構與互聯基礎設施，副教授強調道。 他還指出，將機構、貿易機制與貨幣作為“武器”會侵蝕穩定的世界秩序。Gulshan Sachdeva 堅信，BRICS 及其他框架內需要替代性解決方案。 HSE University 副校長、BRICS-Russia Expert Council 負責人、俄羅斯 Women's Twenty 特使 Victoria Panova 認為，西方夥伴仍然保持一種不受約束的姿態，並視自己為唯一的決定性玩家。她指出，西方機構的金融杠杆——美元支付系統、倫敦保險體系、對集裝箱航運的控制——實質上賦予了他們優勢，並形成了“主導對話”的幻覺。 “在這種背景下，BRICS 的作用確實無可替代。儘管西方同行試圖分化該組織，BRICS 已經證明了其相關性和在經濟、金融以及三大合作支柱上提出新倡議的能力。各國間的相互依存依然存在，包括與西方、歐盟、美國的關係，但一種更加多極化的新經濟正在形成。看看數據：自首屆峰會以來，BRICS 內部貿易額已增長 3.5 倍——這是參與國積極合作、共同促進增長、減少對西方依賴的客觀證據。”她強調。 BRICS 國家正在創建新的機構與機制，幫助成員加強經濟獨立。其中一個專案是 contingent reserve arrangement（應急儲備安排）。Victoria Panova 表示，該專案仍需完善，但已展現出聯盟多元化金融工具、減少對西方結構依賴的意圖。 “BRICS 的 New Development Bank（新開發銀行） 已經啟動了實際舉措：已發行人民幣和蘭特債券，盧比債券正在籌備中。目前該銀行約 30% 的業務以本幣進行。一項約 350 億美元的投資計畫旨在縮小全球南方國家的基礎設施差距並支持其長期發展。”她強調。 Victoria Panova 補充道，BRICS 正逐步實現國際架構的平衡，不介入制裁或反制裁的邏輯，而是通過實際舉措幫助各國實施其發展計畫並保護公民利益。 開放對話的參與者還討論了如何吸引投資進入 International North-South Transport Corridor（國際南北運輸走廊）、BRICS+ 線路、大陸鐵路專案，以及加強 EAEU、非洲與 ASEAN 聯繫的國際物流挑戰與措施。 Infra Projects LLC 管理合夥人 Alexey Bezborodov 就“提升 BRICS 國家物流互聯的新方案”發表講話。他指出，世界已經進入集裝箱化時代，集裝箱將成為全球非能源領域貿易的基本單位。這位專家還表示，俄羅斯完全有能力在 BRICS 內部發揮關鍵的中轉作用：尤其是通過 Trans-Siberian Railway（西伯利亞大鐵路） 和 North-South 通道 的基礎設施，對中國和印度具有戰略意義。 “如今，碎片化、集裝箱化、局部經濟增長和電子商務使我們能夠說，地理認知、貨物運輸速度、最終交付方式以及生產合作模式都在發生變化。本質上，基礎設施與物流領域正在發生一場靜悄悄的革命。”Alexey Bezborodov 表示。 同時，他強調，如今的基礎設施建設“消耗各國大量資源”，而新建或現代化的設施並非總是耐用，往往在 5–10 年內就會耗盡潛力。 “因此，我們需要考慮新的運輸原則——基於小單元、新型管道式貨物運輸、新物理學與新型能源。”Alexey Bezborodov 指出。 這位專家強調，俄羅斯已有多條貿易與物流線路正在成功發展，包括 Northern Sea Route（北方航道） 與 Transarctic Transport Corridor（跨北極運輸走廊）。還有一個重要的聯合投資專案——North Siberian Railway（北西伯利亞鐵路），通過新增連接線，可連通 October、Northern、Sverdlovsk 與 West Siberian 鐵路。 “首先，我們必須繼續發展現有的經典標準中轉線路——從中國經哈薩克斯坦、俄羅斯、白俄羅斯至歐洲。它如今已存在並為所有參與方帶來收益。”他指出。

Hong Kong - 2025年9月01日 - (SeaPRwire) - SeaPRwire，領先的新聞傳播平臺，推出了一款創新的自動化新聞摘要工具，該工具由SeaPRwire與合作夥伴Asia Presswire (https:/asiapresswire.com) 共同開發。該先進系統利用尖端的自然語言處理（NLP）技術，自動生成簡潔準確的新聞摘要，幫助用戶快速掌握新聞要點，提升閱讀體驗。 隨著新聞內容量的不斷增加，讀者越來越難以在大量的文章中快速獲取關鍵資訊。這一挑戰促使SeaPRwire開發出一個解決方案，簡化新聞消費過程。新的自動化新聞摘要工具正是為此需求而生，提供了一種快速高效的方式來總結新聞文章，節省時間並提升整體用戶體驗。 "我們推出自動化新聞摘要工具是新聞消費變得更快速、更高效的關鍵一步，"SeaPRwire資訊總監Max Jackson表示。"通過利用自然語言處理技術，我們能夠提供一款工具，幫助用戶不僅能夠迅速抓取新聞的核心內容，還能增強與內容的互動性。在這個時間寶貴、讀者希望輕鬆獲取資訊的時代，這一工具尤為重要。" 該工具旨在掃描和分析新聞內容，提取最重要的細節並以清晰、簡潔的格式呈現。它確保了新聞的本質得到保留，同時去除不必要的細節。用戶現在可以在幾秒鐘內查看突發新聞、新聞稿和其他文章的摘要，從而在不需要大量閱讀長篇文章的情況下，及時跟進最新動態。 通過提供自動化新聞摘要解決方案，SeaPRwire旨在幫助企業、媒體和公關專業人士更好地管理資訊流。通過快速傳播摘要內容，組織能夠更有效地與受眾互動，並在不讓受眾感到資訊超載的情況下保持其知情。 "這一工具能夠快速而準確地生成新聞摘要，將顯著影響組織如何處理新聞發佈和內容互動，"Jackson補充道。"在快節奏的數字環境中，這一工具使用戶能夠做出更明智的決策，並幫助他們在競爭環境中保持領先。" SeaPRwire與Asia Presswire的合作確保該系統採用了最新的自然語言處理技術，使其成為任何組織通訊策略中寶貴的補充。通過實現更快速、更高效的內容消費，自動化新聞摘要工具將徹底改變新聞的消費和共用方式。 這一新工具現已向SeaPRwire在多個地區的客戶開放，為那些希望簡化新聞互動並跟上現代媒體快速發展的組織提供了一個重要資源。 關於Asia Presswire   Asia Presswire (https:/asiapresswire.com)是一家新聞稿發佈服務公司，為全球公關公司、代理機構、組織和企業提供定制化解決方案。他們專注於提供定制化的新聞稿分發服務，包括通過電子郵件直接發送新聞稿給報紙、雜誌和廣播媒體編輯。其廣泛的網路覆蓋172個國家，連接超過230,000個媒體管道以及360萬個自媒體平臺。Asia Presswire支持超過46種語言，包括英語、中文、法語、德語和日語，確保在多語言區域內實現有效溝通。其服務旨在提升品牌的線上可見性和聲譽，有效地與目標受眾建立聯繫。 關於SeaPRwire   SeaPRwire是亞洲領先的媒體傳播管理平臺，旨在賦能公關和傳播專業人士。其品牌洞察計畫通過將客戶與80,000多名記者、編輯、雜誌和線上媒體平臺連接，簡化了傳播管理，同時還與3億多關鍵意見領袖（KOL）粉絲網路對接。借助AI技術，SeaPRwire幫助用戶識別相關媒體和KOL，個性化推介內容，並衡量傳播效果。SeaPRwire在包括日本、中國、韓國、香港、新加坡、越南、泰國、馬來西亞、印尼和菲律賓等地區運營，有效提升品牌認知並教育受眾。 媒體聯繫 Brand: SeaPRwire Contact: Media team Email: cs@seaprwire.com Website: https://seaprwire.com

Local social media has erupted over an extraordinary story that has captured the attention of thousands. A Gen Z player, known only as "V," turned a modest RM7,000 stake into a jaw-dropping RM2.3 MILLION on Asia's top-rated online entertainment platform, sureWin — and successfully walked away with every cent in cash. For years, online players and observers alike have debated one question: Can you really cash out such massive winnings from an online platform? This story has delivered the loudest answer yet. Photos and videos of the cash payout quickly went viral, showing bundles of money packed into a suitcase with the sureWin logo. "First time seeing someone actually cash out online winnings in full," one comment read, echoing the disbelief shared by many. A Bold Move That Changed Everything During his streak, V placed a single bet of RM500,000 — an amount equivalent to the price of a condominium unit in Malaysia. That wager became the most memorable moment of the run, one that set him apart and solidified his story as legend among peers. "When I clicked confirm on that bet, my heart was racing. It's not every day you put down the price of a condo in one go," V laughed. "But when it paid off, I knew this was something I'd never forget." From Skepticism to Belief In an interview, V admitted that he was deeply skeptical about whether the platform would ever honor such a large payout. "Honestly, I never believed an online platform would pay out. But when I held RM2.3M in cash in front of me, I was shaking all over," he recalled. To his surprise, the process was flawless. sureWin's team immediately contacted him to verify the withdrawal, then arranged a secure and transparent handover of the winnings. From start to finish, the entire process was seamless — proving that not only can jackpots be won, but they can also be fully withdrawn. Readers can also click here to watch the exclusive video interview on Instagram or watch it on YouTube for the winner’s full reaction. sureWin: Asia's No.1 Top-Rated Platform sureWin is not just any platform — it is widely recognized as Asia's most top-rated online entertainment brand, with over 1,500 genuine reviews on Trustpilot and an average rating of 4.5 stars. The platform holds a legitimate overseas license and has built its reputation by sponsoring major international events across Malaysia and Singapore, including the Alan Walker World Tour, Unstop Music Festival, Neon Festival, as well as partnerships with BIGBANG Daesung LIVE in Singapore and the Black Eyed Peas Singapore 2025 concert. This record-breaking payout is further proof of sureWin's promise to deliver on its slogan: Easy to Win, Stable, and Worry-Free. A Cultural Shift Among Gen Z Industry observers suggest this story is about more than just a massive jackpot. It reflects a wider cultural shift: for Millennials and Gen Z, online platforms represent not only gaming, but also a form of social culture, lifestyle, and — in rare cases — a life-changing opportunity. sureWin's Official Response "This win is not only life-changing for the player, but it is also a milestone for the industry. It proves our dedication to transparency, security, and hassle-free payouts. At sureWin, we stand by our promise to be 'Easy to Win, Stable, and Worry-Free.' That means every member can play with confidence, knowing that their experience — from gameplay to withdrawal — is safe and reliable." Conclsion From RM7K to RM2.3M, this real-life story has captured the imagination of young audiences across the region. For the winner, it's a life-changing moment. For sureWin, it's another powerful statement: the brand remains Asia's most trusted name in online entertainment — where players can truly Play Safe, Withdraw Easy, and Win Big.

New York, NY – September 01, 2025 – (SeaPRwire) – me88news, a dedicated sports journalism platform, announced its official launch today, designed to provide comprehensive coverage and expert analysis across four key competitive disciplines: Formula 1, E-sports, Badminton, and Martial Arts. Addressing the Information Gap in Sports Media The launch of me88 news responds to the growing demand for specialized sports content that goes beyond surface-level reporting. Unlike traditional sports platforms that prioritize click-driven headlines, me88 news focuses on delivering substantive analysis, technical breakdowns, and exclusive behind-the-scenes content that enhances readers’ understanding of competitive sports. “The sports media landscape is saturated with recycled content and sensational headlines,” said Owen Parker at me88 news. “Our platform represents a commitment to journalism that respects both the intelligence of our audience and the complexity of modern competitive sports.” Comprehensive Multi-Sport Coverage me88 news provides specialized reporting across four distinct sporting categories: Formula 1: Technical analysis covering paddock politics, pit lane strategies, and the engineering innovations that define modern motorsport E-sports: Tournament coverage, player profiles, and analysis of the rapidly evolving digital athletics landscape Badminton: In-depth coverage of one of the world’s most physically demanding racket sports, featuring tactical analysis and athlete profiles Martial Arts: Comprehensive reporting spanning traditional disciplines to modern competitive fighting, honoring both heritage and contemporary innovation Real-Time Global Coverage The platform operates with around-the-clock reporting capabilities, ensuring readers receive timely updates regardless of global time zones. Features include live event coverage, instant post-competition analysis, and multimedia content including highlight reels and exclusive interviews. Beyond breaking news, me88 news offers editorial content designed to foster informed discussion within the sports community, including opinion pieces, feature stories, and long-form investigations into the human stories behind athletic achievement. Industry Positioning and Future Outlook me88 news enters a competitive digital sports media market with a differentiated approach focused on quality over quantity. The platform’s launch reflects broader industry trends toward specialized content and expert analysis as audiences increasingly seek authoritative sources for sports information. The company plans to expand coverage areas and enhance multimedia offerings as the platform develops its audience base and establishes its position within the sports media ecosystem. About me88 news me88 news is a sports journalism platform dedicated to providing comprehensive coverage and analysis across multiple competitive disciplines. Through strategic partnerships and expert-driven content, me88 news serves sports enthusiasts seeking in-depth analysis that enhances their understanding and appreciation of competitive athletics. Media Contact Company: me88 news Contact: Media Team Email: hello@me88news.com Website: https://me88news.com/

連續 8 年年化回報超 20%，Duoer Capital 再次升級戰略，以「安全+合規」為投資人保駕護航 【2025年·新加坡】在全球市場波動與不確定性加劇的背景下，投資者愈發關注 穩健收益與資金安全。Duoer Capital Management Co.,Ltd 今日宣布，將全面啟動新基金計劃，以 AI + Web3 為核心驅動，為投資人開啟數字經濟新藍海。 連續八年穩健表現 Duoer Capital 的旗艦量化基金已連續八年實現 20%+ 年化回報，夏普比率保持在行業領先的 2.0+ 水平，最大回撤始終低於 15%。這一紀錄展現了公司在風險控制與超額收益方面的專業實力。 雙軌並行：傳統+數字資產 新基金將採取「雙軌策略」： 傳統市場：股票、期貨等繼續由 AI 增強策略驅動； 數字市場：重點布局加密資產、DeFi 與 NFT，捕捉下一代數字經濟紅利。 安全合規：投資人的信心保障 Duoer Capital 特別強調合規與安全： 全球監管許可：已獲得 SEC、FCA、SFC 認可，並持有 美國 MSB 金融牌照，合法開展數字資產與跨境支付業務； 風險管理體系：LVaR、鏈上風險評級、熔斷機制全方位保障； 安全審計：與國際頂尖安全機構合作，確保 DeFi 協議與智能合約的穩健性。 即將推出：AI 驅動數字資產基金 2025 年，公司將推出首隻 AI 驅動數字資產基金，由 AI 多因子模型自動化管理投組，並在鏈上進行透明執行，確保投資人全程可追溯、可驗證。 結語 對投資人而言，Duoer Capital 不僅是一家基金公司，更是一個 可信賴的合規投資入口。在 AI 與 Web3 的賦能下，公司將為投資人帶來 穩健回報、合規保障、前瞻機遇。

New York, NY – August 28, 2025 – (SeaPRwire) – As part of its launch, Poolbetx (https://poolbetx.com) proudly introduces its Token (PBX), a stable crypto coin designed as a digital igaming chip for the Poolbetx ecosystem. Built on TON Blockchain: PBX runs on the highly scalable TON blockchain, ensuring speed, low fees, and reliability. Global Accessibility: PBX can be accessed and traded across all major DEX pools including DeDust.io and Ston.fi. Wallet Integration: Customers can easily buy, exchange, or cash out PBX tokens directly through Telegram Wallet and TON Hub Wallet, available on the Apple App Store and Google Play Store. Borderless & Jurisdiction-Free: PBX enables seamless global usage, allowing Poolbetx players to withdraw, play, and transact without jurisdictional restrictions – a world-first innovation in crypto igaming platforms. “PBX is more than a token – it’s a bridge between our global customers and the Poolbetx ecosystem,” said a Poolbetx spokesperson. “By making PBX accessible on everyday apps like Telegram and Tonhub, we’re ensuring anyone, anywhere, can join Poolbetx with ease.” With PBX, Poolbetx not only provides premium i- games but also a financial infrastructure that redefines global access to entertainment. Related Links Telegram: https://t.me/poolbetx PBX on DeDust: https://dedust.io/ PBX on Stonfi: https://ston.fi/ Media contact Brand: Poolbetx Contact: media team Email: support@poolbetx.com Website: https://poolbetx.com

New York, NY – August 27, 2025 – (SeaPRwire) – T-RIZE Group, a global fintech firm offering institutional-grade tokenization infrastructure, is launching Vision 60 by Ste-Rose, a $24.2 million, 60-unit energy-efficient residential development in Laval, Québec. This project is part of a 500+ unit new construction deal with T-RIZE Group, valued at $200 million. Tokenized by T-RIZE, the offering is being launched through a strategic collaboration with Republic, one of the world’s leading regulated investment platforms with over 3 million users, $3 billion in deployed capital, and more than 2,500 ventures backed. Accredited investors will be able to participate using both fiat and cryptocurrency. Pipeline Execution in Motion Vision 60 by Ste-Rose follows Vision 87 by Champfleury, an 87-unit, $23 million tokenized offering that forms part of a separate $300 million, 956-unit residential development. Together, these offerings reflect the ongoing execution of T-RIZE’s multi-billion-dollar pipeline, applying a scalable, compliant framework for bringing real-world assets onchain. T-RIZE leads tokenization, including asset digitization, legal structuring, and smart contract deployment. Republic’s affiliate broker-dealer, OpenDeal Broker LLC , Member FINRA & SiPC, oversees investor onboarding and distribution under Regulation D. Token-Powered Infrastructure Vision 60 will be deployed on an EVM-compatible blockchain such as Base or Avalanche, two leading infrastructures supporting institutional adoption of real-world assets. Base, incubated by Coinbase, enables low-cost execution, robust security, and seamless integration with Ethereum and capital markets ecosystems, offering a strong foundation for tokenized financial products. Avalanche delivers high-performance infrastructure with flexible tooling, supporting regulatory alignment and scalable deployment of institutional tokenization use cases. The $RIZE utility token anchors the T-RIZE ecosystem. It is used to access and pay for tokenization services—including onboarding, structuring, and listing—while also unlocking vetted investment opportunities, enabling decentralized governance, and supporting ecosystem growth. With 30% of supply allocated to governance and incentives, $RIZE is listed on tier-1 venues like Kraken and Revolut. Built with Institutional-Grade Standards Vision 60 is supported by a network of third-party experts and institutions: ● Ekitas – Legal and tax structuring ● CBRE – Independent project appraisal ● BDO – Return and cash flow projections ● Intact Insurance – Performance bond underwriting ● MA2D – Lead developer ● Concept Habitation Duo Inc. – Property manager ● Republic – Regulated global investment platform T-RIZE also operates as a validator and RWA issuer on the Canton Network, a privacy-first blockchain used by institutions such as Goldman Sachs, Broadridge, and Cumberland, where over $2 trillion in monthly transactions are settled and more than $4 trillion in digital assets are safeguarded. This positions T-RIZE at the intersection of regulated finance and onchain innovation. “Tokenized real estate is no longer a concept—it’s entering its institutional growth phase,” said Madani Boukalba, CEO of T-RIZE Group. “Vision 60 is a real-world proof point of how scalable, compliant infrastructure unlocks global access to tokenized real estate—setting the stage for broader institutional adoption.” About Republic Headquartered in New York City, Republic is a global financial firm operating a network of retail-focused investment platforms and an enterprise digital advisory arm. With a deep track record of legal and technical innovation, Republic is known for providing access to new asset classes to investors of all types. Backed by Valor Equity Partners, Galaxy Interactive, HOF Capital, AngelList and other leading institutions, Republic boasts a global portfolio of over 2,000 companies and a community of nearly three million members in over 150 countries. More than $3 billion has been deployed through investment platforms, funds, and firms within the Republic family of companies with operations established in the US, the UK, EU, the UAE and South Korea. All broker-dealer related securities activity is conducted by OpenDeal Broker LLC, an affiliate of OpenDeal Inc. a registered broker-dealer, and member of FINRA | SiPC, located at 149 5th Avenue, 10th FL, New York, 10010 please check our background on FINRA’s BrokerCheck and Form CRS here.  For additional information, visit https://republic.com/  About T-RIZE Group Founded in 2022, T-RIZE is an institutional tokenization platform onboarding a multi-billion-dollar pipeline of real estate, structured financial products, and AI Energy Offset Reserve Notes. The T-RIZE platform transforms these assets into programmable digital instruments that unlock liquidity, lower capital costs, and enhance underwriting and risk modelling while protecting sensitive data through privacy-preserving AI. At its core, the RIZE token powers tokenization services, connects institutions to vetted investments and AI-driven infrastructure, and supports governance and incentive programs across the ecosystem. For more information, visit www.T-RIZE.io or contact: Press Inquiries: press@T-RIZE.io Head Office: 1155 René-Lévesque West, Suite 2500, Montreal, QC H3B 3X7, Canada Toronto Office: 130 King Street West, Suite 1900, Toronto, ON M5X 1E3, Canada

PALM BEACH, FL – August 25, 2025 – (SeaPRwire) – BlackRidge & Co, an elite global advisory firm, announced that it has established its official headquarters in Palm Beach, Florida, as the region cements its reputation as “Wall Street South.” The move places the firm at the center of one of the fastest-growing financial hubs in the United States, with additional offices in New York, Silicon Valley, London, and Hong Kong. To learn more about BlackRidge & Co, visit www.blackridgeandco.com The BlackRidge & Co leadership team brings a heritage of advising the most prestigious institutions, including Rothschild Asset Management, Deutsche Bank, and ICBC Hong Kong. Beyond advisory services, the firm’s specialty is orchestrating introductions to capital, forging strategic growth partnerships, and working alongside clients to unlock new markets and drive long-term value creation. “At BlackRidge & Co, our mission is to create opportunities that are often inaccessible through traditional channels—pairing extraordinary companies with the investors and capital they need to scale globally,” said Director of Communications, Isaac Meyer.  The migration of capital and talent into South Florida has reshaped the financial landscape. Since Ken Griffin’s Citadel relocated from Chicago to Miami in 2022, major institutions including Goldman Sachs, Blackstone, and Peter Thiel’s Founders Fund have followed, creating a powerful concentration of wealth and influence. Palm Beach has emerged as the crown jewel of this movement, now home to more than 300 hedge funds, private equity firms, and financial institutions. A 2025 Forbes analysis reports that at least 68 billionaires maintain strong ties to Palm Beach, underscoring its position as a magnet for global wealth. About BlackRidge & Co BlackRidge & Co is a global advisory firm headquartered in Palm Beach with hubs in New York, Silicon Valley, London, and Hong Kong. The firm specializes in capital introductions, connecting visionary companies with the world’s most influential financiers, investors, and lenders. Through cultivated relationships and decades of experience, BlackRidge helps clients unlock new opportunities, build partnerships, and create sustainable growth. Media contact Brand: BlackRidge & Co Contact: Isaac Meyer, Director of Communications E-mail: im@blackridgeandco.com Website: https://www.blackridgeandco.com

PALM BEACH, FL – August 25, 2025 – (SeaPRwire) – BlackRidge & Co, an elite global advisory firm, announced that it has established its official headquarters in Palm Beach, Florida, as the region cements its reputation as “Wall Street South.” The move places the firm at the center of one of the fastest-growing financial hubs in the United States, with additional offices in New York, Silicon Valley, London, and Hong Kong. To learn more about BlackRidge & Co, visit www.blackridgeandco.com The BlackRidge & Co leadership team brings a heritage of advising the most prestigious institutions, including Rothschild Asset Management, Deutsche Bank, and ICBC Hong Kong. Beyond advisory services, the firm’s specialty is orchestrating introductions to capital, forging strategic growth partnerships, and working alongside clients to unlock new markets and drive long-term value creation. “At BlackRidge & Co, our mission is to create opportunities that are often inaccessible through traditional channels—pairing extraordinary companies with the investors and capital they need to scale globally,” said Director of Communications, Isaac Meyer.  The migration of capital and talent into South Florida has reshaped the financial landscape. Since Ken Griffin’s Citadel relocated from Chicago to Miami in 2022, major institutions including Goldman Sachs, Blackstone, and Peter Thiel’s Founders Fund have followed, creating a powerful concentration of wealth and influence. Palm Beach has emerged as the crown jewel of this movement, now home to more than 300 hedge funds, private equity firms, and financial institutions. A 2025 Forbes analysis reports that at least 68 billionaires maintain strong ties to Palm Beach, underscoring its position as a magnet for global wealth. About BlackRidge & Co BlackRidge & Co is a global advisory firm headquartered in Palm Beach with hubs in New York, Silicon Valley, London, and Hong Kong. The firm specializes in capital introductions, connecting visionary companies with the world’s most influential financiers, investors, and lenders. Through cultivated relationships and decades of experience, BlackRidge helps clients unlock new opportunities, build partnerships, and create sustainable growth. Media contact Brand: BlackRidge & Co Contact: Isaac Meyer, Director of Communications E-mail: im@blackridgeandco.com Website: https://www.blackridgeandco.com

Hunet Plus Co., Ltd. (CEO Hyukjin Cha), a company specializing in next-generation semiconductor and display materials, announced on Aug. 13th that it has secured Pre-Series B investment for entry into the U.S. market from global semiconductor-related companies, including strategic investors from Japan and Taiwan, as well as the Korean financial investor, ANDA Asia Ventures. In particular, this investment – secured at a time when US and Korea’s tariff issues in the semiconductor sector are coming to the forefront – marks a significant milestone, as it has attracted investment from leading investors from Korea, Japan, and Taiwan. The deal is expected to provide strong momentum not only for securing the original technology of ML-EUV® (Molecular Layer Assembled Extreme UltraViolet Technology, Process and Materials – a multilayer molecular film vacuum process-type photoresist for extreme ultraviolet lithography), but also for obtaining international patents to support market entry into the U.S., Japan and global markets. Furthermore, as one of the few Korean start-up companies to successfully attract foreign investment from Japan and Taiwan, Hunet Plus is expected to gain strong traction in expanding its markets while strengthening its global competitiveness. ML-EUV® is a next-generation total solution for EUV (Extreme Ultraviolet) lithography, encompassing vertically stacked molecular structures, manufacturing processes, and materials. Hunet Plus’ ML-EUV® has overcome the limitations of achieving ultra-high resolution (below 10 nm line width) and sub-2 nm line edge roughness (LER), which have been difficult to realize with existing methods such as: Second-generation chemical amplification resists (wet process, Chemical Amplification Resist) Third-generation inorganic nano-cluster-based resists (wet process, Nano Cluster Based Resist) Fourth-generation inorganic dry-process resists (dry process, Inorganic Precursor Resist) Hunet Plus’ ML-EUV® achieves world-class performance of ultra-high resolution below 10 nm and line edge roughness below 2 nm by using organic precursors and inorganic precursors at the molecular level, forming 10–20 nm ultra-thin multi-layered resist films through its proprietary Organic–Inorganic Molecular Layer Deposition Process® – an innovative dry molecular-layer stacking method. Through this strategic investment, Hunet Plus has formally launched commercialization efforts for ML-EUV®. Based on the world’s highest-performing ML-EUV®, the company plans to jointly commercialize ML-EUV® equipment and processes for dry processing with leading global semiconductor equipment manufacturers, while also supplying core organic and inorganic process materials for ML-EUV®-related semiconductor processes in partnership with global materials companies. In doing so, Hunet Plus aims to position itself as a key player in the semiconductor materials, components, and equipment sector. Hyukjin Cha, CEO of Hunet Plus, stated: “In the global semiconductor market, national borders no longer matter. In the near future, technologies and products like our ML-EUV® – innovative and market-leading – will be the basis for global companies to collaborate and build ecosystems that dominate the market and ensure sustainability. We anticipate additional USD 10 Million follow-on investments from our existing shareholders as well as other global companies, including in the U.S., and will work with local clients to build unique and sustainable ecosystem.” Haesun Kim, Senior Executive Director of HunetPlus, who played a pivotal role in leading the successful domestic and overseas fundraising, drew on more than 25 years of professional experience in international finance and foreign capital attraction, commented: “Although the past two years have been a very challenging period for Hunet Plus – requiring not only navigating detailed and rigorous due diligence imposed by top-tier international investors but also had to lead strategic negotiations – it has been deeply rewarding. In particular, despite a difficult investment climate as well as attracting interest from potential investors to one of the top level industries in the world, this has become a meaningful success story made possible by the organic cooperation with HunetPlus executives.” Cho Namhoon, CEO of K-Ground Ventures, an existing investor and the operator of Scale-Up TIPS who provided behind-the-scenes support for this investment, said: “Even in Korea’s challenging environment for bold investments in original technology, we had a strong belief in Hunet Plus’ global-standard R&D capabilities. Through the Hongneung Advanced Science & Technology Commercialization Fund, we took the bold step of making an early-stage investment, followed by support for subsequent fundraising, reinvestment through the Innovation IP Fund, and additional backing via Scale-Up TIPS. This long-term investment strategy has brought significant results. In particular, the attracting investment from renowned global investors is expected to support U.S. market entry and lead to further follow-on investments, ultimately building a sustainable global supply ecosystem for Korean semiconductor technology through joint Korea–U.S. R&D, production, and marketing.” Meanwhile, on August 6 (local time), U.S. President Donald Trump, at an Apple facility investment announcement event, stated, “We will impose 100% tariffs on every semiconductor imported into the United States.” This announcement has drawn intense attention from semiconductor startups and investors, as semiconductors are the second-largest category of U.S.-bound exports, especially ahead of the upcoming Korea–U.S. summit, where the government’s response will be closely watched. Media contact Brand: Hunet Plus Contact: Hyukjin Cha, CEO Email: support@hunetplus.com Telephone: +82-10-8817-0003 Website: https://en.hunetplus.com

Hunet Plus Co., Ltd. (CEO Hyukjin Cha), a company specializing in next-generation semiconductor and display materials, announced on Aug. 13th that it has secured Pre-Series B investment for entry into the U.S. market from global semiconductor-related companies, including strategic investors from Japan and Taiwan, as well as the Korean financial investor, ANDA Asia Ventures. In particular, this investment – secured at a time when US and Korea’s tariff issues in the semiconductor sector are coming to the forefront – marks a significant milestone, as it has attracted investment from leading investors from Korea, Japan, and Taiwan. The deal is expected to provide strong momentum not only for securing the original technology of ML-EUV® (Molecular Layer Assembled Extreme UltraViolet Technology, Process and Materials – a multilayer molecular film vacuum process-type photoresist for extreme ultraviolet lithography), but also for obtaining international patents to support market entry into the U.S., Japan and global markets. Furthermore, as one of the few Korean start-up companies to successfully attract foreign investment from Japan and Taiwan, Hunet Plus is expected to gain strong traction in expanding its markets while strengthening its global competitiveness. ML-EUV® is a next-generation total solution for EUV (Extreme Ultraviolet) lithography, encompassing vertically stacked molecular structures, manufacturing processes, and materials. Hunet Plus’ ML-EUV® has overcome the limitations of achieving ultra-high resolution (below 10 nm line width) and sub-2 nm line edge roughness (LER), which have been difficult to realize with existing methods such as: Second-generation chemical amplification resists (wet process, Chemical Amplification Resist) Third-generation inorganic nano-cluster-based resists (wet process, Nano Cluster Based Resist) Fourth-generation inorganic dry-process resists (dry process, Inorganic Precursor Resist) Hunet Plus’ ML-EUV® achieves world-class performance of ultra-high resolution below 10 nm and line edge roughness below 2 nm by using organic precursors and inorganic precursors at the molecular level, forming 10–20 nm ultra-thin multi-layered resist films through its proprietary Organic–Inorganic Molecular Layer Deposition Process® – an innovative dry molecular-layer stacking method. Through this strategic investment, Hunet Plus has formally launched commercialization efforts for ML-EUV®. Based on the world’s highest-performing ML-EUV®, the company plans to jointly commercialize ML-EUV® equipment and processes for dry processing with leading global semiconductor equipment manufacturers, while also supplying core organic and inorganic process materials for ML-EUV®-related semiconductor processes in partnership with global materials companies. In doing so, Hunet Plus aims to position itself as a key player in the semiconductor materials, components, and equipment sector. Hyukjin Cha, CEO of Hunet Plus, stated: “In the global semiconductor market, national borders no longer matter. In the near future, technologies and products like our ML-EUV® – innovative and market-leading – will be the basis for global companies to collaborate and build ecosystems that dominate the market and ensure sustainability. We anticipate additional USD 10 Million follow-on investments from our existing shareholders as well as other global companies, including in the U.S., and will work with local clients to build unique and sustainable ecosystem.” Haesun Kim, Senior Executive Director of HunetPlus, who played a pivotal role in leading the successful domestic and overseas fundraising, drew on more than 25 years of professional experience in international finance and foreign capital attraction, commented: “Although the past two years have been a very challenging period for Hunet Plus – requiring not only navigating detailed and rigorous due diligence imposed by top-tier international investors but also had to lead strategic negotiations – it has been deeply rewarding. In particular, despite a difficult investment climate as well as attracting interest from potential investors to one of the top level industries in the world, this has become a meaningful success story made possible by the organic cooperation with HunetPlus executives.” Cho Namhoon, CEO of K-Ground Ventures, an existing investor and the operator of Scale-Up TIPS who provided behind-the-scenes support for this investment, said: “Even in Korea’s challenging environment for bold investments in original technology, we had a strong belief in Hunet Plus’ global-standard R&D capabilities. Through the Hongneung Advanced Science & Technology Commercialization Fund, we took the bold step of making an early-stage investment, followed by support for subsequent fundraising, reinvestment through the Innovation IP Fund, and additional backing via Scale-Up TIPS. This long-term investment strategy has brought significant results. In particular, the attracting investment from renowned global investors is expected to support U.S. market entry and lead to further follow-on investments, ultimately building a sustainable global supply ecosystem for Korean semiconductor technology through joint Korea–U.S. R&D, production, and marketing.” Meanwhile, on August 6 (local time), U.S. President Donald Trump, at an Apple facility investment announcement event, stated, “We will impose 100% tariffs on every semiconductor imported into the United States.” This announcement has drawn intense attention from semiconductor startups and investors, as semiconductors are the second-largest category of U.S.-bound exports, especially ahead of the upcoming Korea–U.S. summit, where the government’s response will be closely watched. Media contact Brand: Hunet Plus Contact: Hyukjin Cha, CEO Email: support@hunetplus.com Telephone: +82-10-8817-0003 Website: https://en.hunetplus.com

SHENZHEN, CHINA, Aug 19, 2025 – (ACN Newswire via SeaPRwire.com) – On 18 August, China Medical System Holdings Limited (“CMS” or the “Company”) announced its interim results for the six months ended 30 June 2025 (the “Reporting Period”), with both revenue and profit recording year-on-year growth, demonstrating the initial results of its strategic transformation. During the Reporting Period, the Company recorded revenue of approximately RMB4.00 billion, representing a year-on-year increase of 10.8%. In the case that all medicines were directly sold by the Company, revenue would be approximately RMB4.67 billion, up 8.9% year-on-year. Net profit was approximately RMB0.93 billion, representing an increase of 3.1% year-on-year. The results reflect that CMS has emerged from the shadow of National Volume-based Procurement (“National VBP”), and its performance is expected to return to a sustainable growth trajectory. Revenue from the Company’s key non-National VBP exclusive/branded products and innovative products (in the case that all medicines were directly sold by the Company) reached approximately RMB2.90 billion, up 20.6% year-on-year, accounting for 62.1% of total revenue. The company’s exclusive/branded products and innovative products have a favorable competitive landscape and high visibility of future growth, and have now become the main drivers of performance growth. According to the interim results announcement, the company has been planning its “New CMS” blueprint since 2018, anchored on the three strategic pillars of “product innovation, commercial model reform, and international expansion” to build a sustainable second growth curve. By the first half of 2025, solid operating results and the steady delivery of innovation outcomes have confirmed that the Company’s strategic upgrade has been gradually translated into tangible achievements. “New Products” Strategy Drives Innovation Value Realization and Solidifies Growth Momentum At the forefront of the Company’s three strategic pillars, the “product innovation” strategy leverages a three-dimensional innovation mechanism of “overseas licensing, domestic collaboration, and in-house R&D” to continuously inject high-value short-, medium- and long-term pipelines, serving as a key growth engine. Currently, the innovation strategy has entered a period of continuous harvest, with new products continuously releasing commercial and clinical value. To date, the Company has successfully commercialized five innovative drugs in China; By 2025, two innovative products — ruxolitinib cream and Desidustat Tablets—are also expected to receive marketing approvals. Ruxolitinib cream is the first and only topical JAK inhibitor approved by the U.S. FDA and the European Medicines Agency for repigmentation in non-segmental vitiligo, and is expected to become the first approved treatment for vitiligo in China, filling a market gap and bringing new hope to Chinese vitiligo patients. Additionally, the New Drug Application (NDA) for the Alzheimer’s disease drug ZUNVEYL in China was accepted in July this year; the consumer healthcare product Poly-L-lactic Acid Microparticle Filler Injection has been approved for marketing, further enriching the Company’s diversified product portfolio. Among the innovative pipeline under R&D, several blockbuster candidates have entered the late-stage clinical development in China and are expected to be commercialized within the next one to three years, forming a new driving force for sustained growth. Among these, the collaborative product Y-3 for Injection has completed Phase III clinical trials in China. This product is an original unimolecular Class 1 innovative drug and the only non-peptide PSD95/nNOS uncoupler that has entered clinical development, with potential to become the first dual-function brain cytoprotectant for treating ischemic stroke while preventing post-stroke depression and anxiety. Another oral small molecule Class 1 innovative drug, ABP-671 (a URAT1 inhibitor) for the treatment of gout and hyperuricemia, is progressing through Phase IIb/III clinical trials in China. Compared with existing mainstream drugs, ABP-671 has the potential to reduce uric acid to lower levels at lower doses and possesses gout-tophus dissolution capability, thereby offering patients a more effective and safer treatment option. CMS continues to expand its innovative pipeline and enhance its end-to-end innovation capabilities to ensure the steady, phased marketing approval of innovative products. In H1 2025, two new collaborative R&D innovative products — ZUNVEYL and MG-K10 (a long-acting anti-IL-4Rα humanized monoclonal antibody injection) — were added to the portfolio. To date, the Company has deployed about 40 differentiated innovative pipeline products, including approximately 20 in-house R&D projects. Advancing “New Models” and “New Markets” Strategies to Unlock Multi-dimensional Growth According to the interim results announcement, CMS continues to advance its “New Models — Commercial Model Reform” strategy, forging anti-cyclical resilience through a diversified ecosystem. It also firmly implements its “New Markets – International Expansion” strategy, building a multi-dimensional growth framework via an industrial internationalization model. Under the commercial model reform strategy, the Company continues to focus on specialty therapeutic fields while expanding into new retail and new media channels, building a comprehensive marketing and promotion system that covers both “in-hospital + out-of-hospital” and “online + offline” channels, and reinforcing its diversified product portfolio with consumer attributes. Its skin health business, Dermavon, has demonstrated strong potential in this particular segment with consumer attributes. Since its independent operation in 2021, Dermavon has achieved dual leadership in both the “coverage of dermatology indications” and the “revenue scale of dermatological prescription drugs”, and is proposed to be spun off and separately listed on the Main Board of the Hong Kong Stock Exchange by way of introduction and distribution in specie, to further unlock its standalone value and high-growth potential. In terms of internationalization, CMS successfully completed its secondary listing on the Main Board of the Singapore Exchange by way of introduction on 15 July 2025, marking a new milestone in its “industrial internationalization” strategy. With Singapore as a hub, the Company has established a comprehensive business system covering the entire value chain of “R&D–Manufacturing–Commercialization” for emerging markets. To date, its commercial platform company, Rxilient, has cumulatively submitted nearly 20 registration applications for pharmaceutical products and medical devices across Southeast Asia, the Middle East, Hong Kong, Macau, and Taiwan Region, covering therapeutic fields such as dermatology, ophthalmology, oncology, autoimmune, and central nervous system. Ruxolitinib cream (vitiligo indication) has been approved for marketing in Macau and Hong Kong, and its registration applications have been submitted in Singapore and Taiwan Region. Intravenous Toripalimab (the first China-originated anti-PD-1 monoclonal antibody drug that has been approved by the China NMPA and the U.S. FDA) has been submitted for registration in five countries, including Malaysia. Tildrakizumab Injection and Sucroferric Oxyhydroxide Chewable Tablets have also been approved for marketing in Hong Kong. Meanwhile, PharmaGend, an associate CDMO manufacturing facility in which CMS holds a 45.0% equity interest, now has an annual production capacity of 1 billion units of oral solid dosage forms (tablets and capsules), and has obtained a drug manufacturing license from Singapore’s HSA, U.S. FDA cGMP certification, and passed Swiss QP audits. The construction of new production lines for nasal sprays, creams, and injectables is progressing steadily, providing high-standard production and delivery capabilities for the international market. Looking ahead, the growth logic of “New CMS” is expected to accelerate its realization, with profitability and performance resilience improving simultaneously. The Company is building a growth framework centered on differentiated innovation, driven by a synergistic and diversified ecosystem, and underpinned by an international footprint. This will open up long-term opportunities for high-quality development, deliver quality pharmaceutical products and services to patients worldwide, and generate sustainable returns for shareholders. About CMS CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs. CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients. CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries, strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology/ophthalmology/ skin health businesses. Among them, the skin health business has become a leading enterprise in its field, bringing economies of scale in specialty therapeutic fields. Meanwhile, CMS continuously deepens its business development in the Southeast Asia and Middle East regions, further escorting the sustainable and healthy development. CMS Disclaimer and Forward-Looking Statements This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert. This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections. Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Source: China Medical System Holdings Ltd. Copyright 2025 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com Categories: ACN Newswire